Evidence map›Paper›PMID 39309723›Full record

ArticleEClinicalMedicine2024

Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi study.

Raymond Javan Chan, Reegan Knowles, Fredrick D Ashbury, Joanne Bowen, Alexandre Chan, Melissa Chin, Ian Olver, Carolyn Taylor, Stacey Tinianov, Paola Alberti and 22 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Barriers and facilitators for implementing patient-reported outcome measures in oncology practices: an umbrella review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Optimising ovarian cancer care: An embedded mixed methods evaluation of a national nurse-led telehealth program.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Scaling up symptom screening for routine use in pediatric oncology: provincial implementation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  7. The current State of supportive care in cancer: a national survey of healthcare providers and patients by the AFSOS.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  8. Observational
  9. Review
  10. Comparing clinical practice guidelines on the prevention and management of chemotherapy-induced hand-foot syndrome.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  11. Article
  12. Article
  13. Promoting lifestyle medicine for supportive care in cancer: MASCC endorsement of the ACLM cancer risk reduction and survivorship toolkit.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Research priorities to address supportive care needs in acute myeloid leukaemia (AML)-results from a Delphi survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Raymond Javan ChanCaring Futures Institute, College of Nursing and Health Sciences, Flinders University, Flinders Drive, Bedford Park, South Australia, Australia.
Reegan KnowlesCaring Futures Institute, College of Nursing and Health Sciences, Flinders University, Flinders Drive, Bedford Park, South Australia, Australia.
Fredrick D AshburyDepartment of Oncology, University of Calgary, Alberta, Canada.
Joanne BowenSchool of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, 230 North Terrace, Adelaide, South Australia, Australia.
Alexandre ChanDepartment of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of California, 802 W Peltason Dr, Irvine, CA, United States.
Melissa ChinMultinational Association of Supportive Care in Cancer, 16 Industrial Parkway South Unit 412, Aurora, ON L4G 0R1, Canada.
Ian OlverSchool of Psychology, Faculty of Health and Medical Sciences, University of Adelaide, 230 North Terrace, Adelaide, South Australia, Australia.
Carolyn TaylorGlobal Focus on Cancer, 26 Hemlock Rd Suite 101, South Salem, NY 10590, United States.
Stacey TinianovAdvocates for Collaborative Education, Santa Cruz, CA, United States.
Paola AlbertiSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Paolo BossiDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan 20072, Italy.
Norman Brito-DellanThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, United States.
Tim CooksleyThe Christie, Wilmslow Rd, Manchester, United Kingdom.
Gregory Brian CrawfordSchool of Psychology, Faculty of Health and Medical Sciences, University of Adelaide, 230 North Terrace, Adelaide, South Australia, Australia.
Niharika DixitDivision of Hematology/Oncology, University of California, San Francisco, CA, United States.
Margaret I FitchBloomberg Faculty of Nursing, University of Toronto, 155 College Str, Suite 130, Toronto, Ontario, Canada.
Jason L FreedmanDivision of Oncology, Children's Hospital of Philadelphia, 3400 Civic Center Blvd, Philadelphia, PA, United States.
Pamela K GinexState University of New York, Nicolls Rd, Stony Brook, NY, United States.
Nicolas H HartCaring Futures Institute, College of Nursing and Health Sciences, Flinders University, Flinders Drive, Bedford Park, South Australia, Australia.
Daniel L HertzDepartment of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church Str, Ann Arbor, MI, United States.
Michael JeffordDepartment of Health Services Research, Peter MacCallum Cancer Centre, 305 Grattan Str, Melbourne, Victoria, Australia.
Bogda KoczwaraFlinders Medical Centre, Flinders Drive, Bedford Park, South Australia, Australia.
Tateaki NaitoDivision of Thoracic Oncology, Shizuoka Cancer Center, Nagaizumi-cho, Sunto-gun, Japan.
Andrea Dahlman OrseyCenter for Cancer and Blood Disorders, Connecticut Children's Medical Center, 282 Washington Street, Hartford, CT 06106, United States.
Christina H RuhlmannDepartment of Oncology, Odense University Hospital, Denmark - Department of Clinical Research, University of Southern Denmark, Denmark.
Nikolaos TsoukalasOncology Department, 401 General Military Hospital of Athens, Greece.
Corina van den HurkR&D Department, Netherlands Comprehensive Cancer Organization (IKNL), Rijnkade 5, Utrecht 3511 LC, the Netherlands.
Ysabella Van SebilleUniversity of South Australia, Level 4, Catherine Helen Spence Building, City West, Adelaide, South Australia, Australia.
Hannah Rose WardillSchool of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, 230 North Terrace, Adelaide, South Australia, Australia.
Florian ScotteGustave Roussy Cancer Campus, 114 rue Edouard Vaillant, Villejuif CEDEX, Paris, France.
Maryam LustbergSmilow Cancer Hospital at Yale, 35 Park Street, Fl 1st, Suite A, New Haven, CT 06511, United States.
Multinational Association of Supportive Care in Cancer (MASCC) Study Group Chairs

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Background: Supportive care to ensure optimal quality of life is an essential component of cancer care and symptom control across the lifespan. Ongoing advances in cancer treatment, increasing toxicity from many novel treatment regimes, and variations in access to care and cancer outcomes across the globe and resource settings present significant challenges for supportive care delivery. To date, no overarching framework has been developed to guide supportive care development worldwide. As an initial step of the Multinational Association of Supportive Care in Cancer (MASCC) Supportive Care 2030 Movement, we developed a targeted, unifying set of ambition statements to envision the future of supportive cancer care. Methods: From September 2022 until June 2023, we used a modified Delphi methodology to develop and attain consensus about ambition statements related to supportive cancer care. Leaders of MASCC Study Groups were invited to participate in an Expert Panel for the first two Delphi rounds (and a preliminary round to suggest potential ambition statements). Patient Advocates then examined and provided input regarding the ambition statements. Findings: Twenty-seven Expert Panelists and 11 Patient Advocates participated. Consensus was attained on 13 ambition statements, with two sub-statements. The ambition statements addressed global standards for guideline development and implementation, coordinated and individualized care, dedicated supportive oncology services, self-management, needs for screening and actions, patient education, behavioral support, financial impact minimization, comprehensive survivorship care, and timely palliative care, reflecting collaboration, coordination and team-based approach across all levels. Interpretation: This study is the first to develop shared ambitions for the future of supportive cancer care on a global level. These ambition statements can facilitate a coordinated, resource-stratified, and person-centered approach and inform research, education, clinical services, and policy efforts. Funding: This project received funding support from Prof Raymond Chan's NHMRC Investigator Grant (APP1194051).

Indexed as

Optimal carePalliative careSupportive careSupportive oncologyToxicity

Identifiers

PMID39309723
PMCPMC11415959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.